Amy L Gillespie

6PUBLICATIONS
30CO-AUTHORS
Regenerative medicine (incl. stem cells)Characterisation of biological macromoleculesPharmacogenomicsDiagnostic radiographyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 17, 2026
Effects on hippocampal activity following novel 5-HT4 receptor agonism in unmedicated patients with depression: the RESTAND study.

|May 28, 2026
Early effects of a novel 5-HT<sub>4</sub>R agonist (PF-04995274) and the SSRI citalopram on emotional cognition in unmedicated depression: RESTAND study.

|May 22, 2025
Effects of 28-day simvastatin administration on emotional processing, reward learning, working memory, and salivary cortisol in healthy participants at-risk for depression: OxSTEP, an online experimental medicine trial.

Riccardo De Giorgi, Shona Waters, Amy L Gillespie

|Dec 23, 2024
Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flow.

Junyu Sun, Fernando Zelaya, Kyra-Verena Sendt

|Sep 27, 2024
Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts.

Amy L Gillespie, Emma M Walker, Eilis Hannon

|Mar 03, 2022
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia.

Fanni Krajner, Laila Hadaya, Grant McQueen

Pageof 1

Frequent Collaborators

3 joint publications

James H MacCabe

3 joint publications

Alice Egerton

3 joint publications

Philip J Cowen

2 joint publications

Beata R Godlewska